ArticleFrontiers in pharmacology2025

Real-world analysis of immunochemotherapy in recurrent small-cell lung cancer: opportunities for second-line approaches.

Yanrong Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.